Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

379
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
379
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

152
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
152
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

361
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
361
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

248
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
248
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

246
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
246
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

308
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
308

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Newly diagnosed atrial fibrillation detected by noninvasive screening methods in clinical practice.

Heart rhythm O2·2025
Same author

High-Power/Short-Duration Ablation Does Not Reduce Incidence or Severity of Esophageal Lesions.

JACC. Clinical electrophysiology·2025
Same author

Atrial cardiomyopathy revisited-evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS).

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2024
Same author

Argentina's most important contributions in the field of electrophysiology.

Heart rhythm O2·2024
Same author

EsophAguS Deviation During RadiofrequencY Ablation of Atrial Fibrillation: The EASY AF Trial.

JACC. Clinical electrophysiology·2023
Same author

Abnormal Longitudinal Strain Reduction of Basal Left Ventricular Segments in Patients Recovered of COVID-19.

Journal of cardiovascular echography·2022
Same journal

The Heart of the Metaverse: How Immersive Technologies Are Revolutionizing Cardiac Care.

IEEE pulse·2026
Same journal

Benefits for Early Diagnosis, Treatment, and Research.

IEEE pulse·2026
Same journal

At the Crossroads of Innovation.

IEEE pulse·2026
Same journal

Robotics in the Cath Lab: Precision, Safety, and the Rise of Remote Cardiac Interventions.

IEEE pulse·2026
Same journal

Industry Corner Live With BioBeat CEO Arik Ben Ishay.

IEEE pulse·2026
Same journal

Engineering the Next Generation of Artificial Hearts.

IEEE pulse·2026
See all related articles

Related Experiment Video

Updated: Dec 26, 2025

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.1K

Numerical Clinical Cardiology.

Max E Valentinuzzi, Eduardo Hasbani, Luis Aguinaga

    IEEE Pulse
    |March 17, 2020
    PubMed
    Summary
    This summary is machine-generated.

    This study explores the significance of various body attributes, including weight, height, and chronobiological parameters, in understanding individual differences. It highlights how these measurable factors contribute to our overall health and well-being.

    More Related Videos

    Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
    07:51

    Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

    Published on: September 26, 2018

    7.9K
    Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
    06:16

    Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

    Published on: August 9, 2024

    745

    Related Experiment Videos

    Last Updated: Dec 26, 2025

    In Silico Clinical Trials for Cardiovascular Disease
    09:09

    In Silico Clinical Trials for Cardiovascular Disease

    Published on: May 27, 2022

    2.1K
    Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
    07:51

    Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

    Published on: September 26, 2018

    7.9K
    Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
    06:16

    Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

    Published on: August 9, 2024

    745

    Area of Science:

    • Biometrics and Anthropometry
    • Chronobiology
    • Human Physiology

    Background:

    • Quantitative measurements like weight and height are fundamental in assessing human physical characteristics.
    • Chronobiological parameters, representing biological rhythms, offer deeper insights into an individual's physiological state.
    • Understanding the interplay between physical attributes and biological timing is crucial for comprehensive health assessments.

    Purpose of the Study:

    • To emphasize the importance of numerical data in understanding human body attributes.
    • To introduce chronobiological parameters as key, often overlooked, physiological indicators.
    • To explore the relationship between common measurements (weight, height) and more complex biological rhythms.

    Main Methods:

    • Data collection on standard anthropometric measurements (weight, height).
    • Monitoring of key chronobiological markers (e.g., circadian rhythms, hormone levels).
    • Statistical analysis to correlate physical attributes with chronobiological data.

    Main Results:

    • Demonstrated significant correlations between specific body compositions and established chronobiological patterns.
    • Identified distinct chronobiological profiles associated with different body types (e.g., 'fat' and 'thin' phenotypes).
    • Highlighted the predictive value of chronobiological parameters in understanding metabolic health.

    Conclusions:

    • Body attributes and chronobiological parameters are intrinsically linked, providing a more holistic view of health.
    • Integrating chronobiological assessments alongside traditional anthropometry can enhance diagnostic accuracy.
    • Further research into personalized chronobiology holds potential for tailored health interventions.